Cordis Corporation (JNJ) Showcases Cardiovascular Innovations at EuroPCR 2013
5/21/2013 7:34:07 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Cordis Corporation, a global leader in innovative technology for cardiovascular interventions, will introduce the two latest additions to its portfolio of cardiovascular solutions at EuroPCR 2013, 21-24 May in Paris. EuroPCR is Europe’s largest meeting for interventional cardiovascular medicine.
Help employers find you! Check out all the jobs and post your resume.
comments powered by